The Connective Tissue Disease Market is also driven by the demand for personalized treatment strategies. Differences in symptoms, disease severity, organ involvement, and medication tolerance make individualized care an important part of long-term disease management. The Connective Tissue Disease Market was valued at US$ 6.67 billion in 2025 and is expected to reach US$ 11.77 billion by 2034,...